The University of Wisconsin's Carbone Cancer Center has partnered with TAE Life Sciences to introduce a new cancer therapy.
This partnership will provide the School of Medicine and Public Health with the first accelerator-based neutron capture therapy machine in North America, aiming
to give hope to patients that don’t have good treatment options today.
NCT is not a new technology for cancer treatment, but it includes two major technological advances: clinical neutron accelerators and molecular-targeted neutron capturing drugs, according to Zachary Morris, UW associate professor and chair of the Department of Human Oncology.
Author summary: UW introduces new cancer therapy.